Biocontrol & Biostimulant Latam - Conference Day One - ET (Eastern Time, GMT-05:00)
Biocontrol & Biostimulant Latam - Conference Day One - ET (Eastern Time, GMT-05:00)
- Market growth in LATAM- a breakdown looking at various countries
- Which region has seen most growth?
- What are forward growth predictions looking like?
- Crescimento do mercado na LATAM - uma análise detalhada de vários países
- Qual região registrou o maior crescimento?
- Quais são as previsões de crescimento futuro?
- Mark Trimmer, PhD - Co Founder, Dunham Trimmer
• Revenue and sales of the bioinnoculant market – an analysis
• Regulatory developments for biofertilizers (brief review)
• Industry challenges
• Industry opportunities
• Receita e vendas do mercado de bioinoculantes - uma análise
• Desenvolvimentos regulatórios para biofertilizantes (breve revisão)
• -Desafios do setor
• Oportunidades do setor
- Julia Emanuela - Director of Institutional and Regulatory Relations, ANPII
- What questions must we consider when looking to enter latam markets?
- How do we go about setting up distribution channels?
- How do we decide what region works best for our product?
- Que questões devem ser consideradas quando se busca entrar nos mercados latino-americanos?
- Como podemos estabelecer canais de distribuição?
- Como decidir qual região é melhor para o nosso produto?
- Antonio Zem - CEO, Biotrop
- Francisco Manzano - Director of Global Business Development, Nutrien
- Cristiano Belle - Nematology Researcher, Staphyt
Plant Parasitic Nematodes affect a broad range of crops causing serious economic losses worldwide. Here we report the discovery of a novel strain of Bacillus thuringiensis with efficacy against a broad spectrum of Plant Parasitic Nematodes and Soil insects. Unlike other products based on Bacillus thuringiensis, this proprietary strain BEC168 is a robust root colonizer and shows broad spectrum effects against many species of nematodes, as well as coleopteran insects. Discovered using the Advanced Microbial Selection process, data shows compelling nematode controlling effects in in-planta growth-chambers and greenhouse bioassays, showing important galling and egg mass reductions. This data was subsequently confirmed in numerous field trials, and different crops, over a 3-year period. BEC168 has demonstrated strong yield improvements and nematode control, with consistent soil nematode count reductions of a broad spectrum of plant parasitic nematodes, in the field, in over 39 internal trials, when applied as a seed treatment. In addition to its nematocidal activity, BEC168 demonstrated insecticidal effects in in-vitro and in the field. BEC168 is an aggressive root colonizer, promotes plant growth also in the absence of pest, and directly affects the nematodes, showing striking effects on population control and molting inhibition. BEC168 produces an interesting array of actives, within them 5 Cry proteins. BEC168 will be commercialized in key corn, soybean and vegetable growing regions, beginning in Brazil and USA. Trials have shown the product competes favorably with chemical nematicides and insecticides, as well as bionematicide products.
- Debora Wilk - Director Plant Pathology, Bioconsortia
- Sergio Luiz de Almeida - Technical and Regulatory Affairs Manager, Plant Healthcare
There is a dire need for new sustainable solutions in the crop protection market. The segment of bacterial diseases, specifically, saw very little innovation in the past few decades, resulting in old products with harmful toxicity, increased resistance levels, and gradual reduction of efficacy. It is estimated that 20% - 30% of the yield in many crops worldwide is lost as a direct result of bacterial diseases. Bacteriophages (or phages for short) have been suggested as an ecologically friendly and safe solution for bacterial diseases of crops. Phages are natural viruses that attack and efficiently kill bacterial pathogens. These viruses infect only bacteria, are harmless to humans and plants, and are biodegradable. Although phages held promise as antibacterials, large knowledge and technological gaps so far prevented their usage as efficient crop protection agents. EcoPhage, established in 2018, has licensed a unique technology from the Weizmann institution that allows the discovery and development of phage-based products exceptionally efficacious for treatment of bacterial pathogens in agriculture. The technology is based on revolutionary discoveries from the Weizmann Institute that revealed how phages can overcome natural bacterial defenses, paving the way to using phage as antimicrobials. Based on this new technology, EcoPhage has developed multi-phage cocktail formulations targeting various diseases, and is working with leading players in the industry to verify these formulations. We show that our phage-based formulations reduce disease severity in both greenhouse and open field experiments, resulting in higher yield in marketable fruits
- Guy Elitzur - CEO, Ecophage
- Giuliano Pauli - Innovation and Marketing Director, Superbac